Contineum Therapeutics Files Annual Report
Ticker: CTNM · Form: ARS · Filed: Apr 30, 2026 · CIK: 0001855175
| Field | Detail |
|---|---|
| Company | Contineum Therapeutics, Inc. (CTNM) |
| Form Type | ARS |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceutical
TL;DR
Contineum filed its 2025 annual report. Check it for deets.
AI Summary
Contineum Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 30, 2026, for the period ending December 31, 2025. The filing includes a PDF document of the report and a complete submission text file. Contineum Therapeutics is a pharmaceutical company based in San Diego, California.
Why It Matters
This filing provides shareholders with an overview of the company's performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not contain new material events or financial distress indicators.
Key Players & Entities
- Contineum Therapeutics, Inc. (company) — Filer
- 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (location) — Mailing and Business Address
- 2025-12-31 (date) — Period of Report
- 2026-04-30 (date) — Filing Date
FAQ
What is the CIK number for Contineum Therapeutics, Inc.?
The CIK number for Contineum Therapeutics, Inc. is 0001855175.
When was the ARS filing accepted by the SEC?
The ARS filing was accepted on 2026-04-30 at 16:13:56.
What is the fiscal year end for Contineum Therapeutics, Inc.?
The fiscal year end for Contineum Therapeutics, Inc. is 1231.
What is the SIC code for Contineum Therapeutics, Inc.?
The SIC code for Contineum Therapeutics, Inc. is 2834, which falls under Pharmaceutical Preparations.
What is the file number for Contineum Therapeutics, Inc.?
The file number for Contineum Therapeutics, Inc. is 001-42001.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 30, 2026 regarding Contineum Therapeutics, Inc. (CTNM).